Market Research Report
Biochips Market By Product Type, Technology, Application and by Geography - Global Trends and Forecast to 2025
|Published by||Coherent Market Insights||Product code||629666|
|Published||Content info||152 Pages
Delivery time: 2-3 business days
|Biochips Market By Product Type, Technology, Application and by Geography - Global Trends and Forecast to 2025|
|Published: April 3, 2018||Content info: 152 Pages||
Biochip technology holds applications in areas such as diagnosis of infectious diseases, respiratory diseases, cancer, and for personalized treatment. Microarray or biochip technology could prove beneficial, as prevalence of these diseases is increasing worldwide. Complexity of the technology, necessary resources in terms of manufacturing, and research and development of these products reflects in terms of high prices. Although the product helps in reducing costs incurred in laboratory methods, the biochip technology itself is still costly. Manufacturers and universities are focused on improving technology of the biochips in order to increase the precision of the results while lowering the costs and time. For instance, researchers from Stanford University School of Medicine had developed a method to produce cheap and reusable diagnostic lab-on-a-chip with the help of an inkjet printer, which was worth 1 cent per chip, in 2017.
Miniaturization of laboratory facilities to save time and costs and extensive product portfolios with wide number of applications of biochips offered by manufacturer’s drives growth of biochips market. Manufacturers offer technologically advanced products in order to minimize time and costs, and improve research outcomes. For instance, Micralyne, Inc. launched Silicon MicraFluidics technology, a line of standardized microfluidic process technologies, which enabled rapid design and deployment of microfluidic-based products in February 2018. Technological advancements in biochips platform, ongoing research and development to widen the applications, and advantages offered by biochip technologies over conventional laboratory with respect to time, costs, and ease of use is expected to fuel growth of the market.
This report provides in-depth analysis of biochips market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2016 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global biochips market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key companies covered as a part of this study include Randox Laboratories, Fluidigm Corporation, Abbott Laboratories, Agilent Technologies, Inc., ThermoFisher Scientific, Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., and PerkinElmer, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global biochips market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the biochips market